Please use this identifier to cite or link to this item:
|Title:||Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions|
|Source:||Shahrizaila, N., Yuki, N. (2011-09). Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions. Expert Review of Neurotherapeutics 11 (9) : 1305-1313. ScholarBank@NUS Repository. https://doi.org/10.1586/ern.11.114|
|Abstract:||Guillain-Barré syndrome (GBS) is typically classified into two major subtypes: acute inflammatory demyelinating neuropathy and acute motor axonal neuropathy. Its most recognizable variant is Fisher syndrome. The last two decades have seen considerable advances in our understanding of GBS. Of note, various autoantibodies against ganglioside antigens have been identified and found to have significant associations with the axonal forms of GBS and Fisher syndrome. In this article, we discuss the different clinical presentations in GBS and the role of antiganglioside antibodies in their underlying pathogenesis. We also discuss the impact that antiganglioside antibodies have had in the development of experimental models and treatment modalities in GBS. © 2011 Expert Reviews Ltd.|
|Source Title:||Expert Review of Neurotherapeutics|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jan 16, 2018
WEB OF SCIENCETM
checked on Nov 21, 2017
checked on Jan 13, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.